

QUICK LINKS
SEE ALSO...
Freund′s Incomplete Adjuvant (FIA) is a crucial component in scientific research, particularly in immunology and vaccine development. Its mechanism of action lies in its ability to enhance immune responses to antigens by creating an immunogenic environment without the use of complete adjuvants like Freund′s Complete Adjuvant (FCA). FIA typically consists of mineral oil combined with surfactants but lacks the mycobacterial components present in FCA, making it safer for use in research. Upon administration, FIA forms a depot at the injection site, allowing for the slow release of antigens and sustained exposure to immune cells. This results in the activation and maturation of antigen-presenting cells, such as dendritic cells, which subsequently prime and activate antigen-specific T and B lymphocytes. Researchers utilize FIA extensively in experimental models to induce controlled immune responses, making it particularly suitable for studies where excessive inflammation or granuloma formation, typical of FCA, is undesirable. FIA is instrumental in vaccine development, immunization protocols, and investigations into immune regulation and host defense mechanisms, providing valuable insights into the modulation of immune responses and the development of novel immunotherapeutic strategies.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Freund′s Incomplete Adjuvant | sc-3726 | 5 x 10 ml | $49.00 |